Tvardi Therapeutics, Inc. (NASDAQ:TVRD) has 66 institutional investors with active 13F positions as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Slate Path Capital LP | 31 Mar, 2026 | 704,118 | 0 | 0.00% | $2,239,095.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 388,075 | -2,925 | -0.75% | $1,234,077.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 344,708 | 344,708 | 0.00% | $1,096,171.00 |
| American Financial Group Inc | 31 Mar, 2026 | 223,659 | 0 | 0.00% | $711,236.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 182,339 | 25,206 | 16.04% | $579,957.00 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 31 Mar, 2026 | 101,034 | 0 | 0.00% | $321,288.00 |
| State Street Corp | 31 Mar, 2026 | 97,231 | -18,270 | -15.82% | $309,195.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 92,100 | -12,400 | -11.87% | $292,878.00 |
| Morgan Stanley | 31 Mar, 2026 | 72,894 | -11,572 | -13.70% | $231,803.00 |
| Duncan Williams Asset Management, LLC | 31 Mar, 2026 | 63,241 | -17,530 | -21.70% | $201,106.00 |
| UBS Group AG | 31 Mar, 2026 | 50,454 | 14,899 | 41.90% | $160,444.00 |
| Northern Trust Corp | 31 Mar, 2026 | 49,081 | 1,199 | 2.50% | $156,078.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 46,872 | 46,872 | 0.00% | $149,053.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 42,192 | 42,192 | 0.00% | $134,171.00 |
| GREAT LAKES ADVISORS, LLC | 31 Mar, 2026 | 36,236 | 36,236 | 0.00% | $115,230.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 33,833 | 33,833 | 0.00% | $107,589.00 |
| Squarepoint Ops LLC | 31 Mar, 2026 | 32,676 | -19,107 | -36.90% | $103,910.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 23,898 | -42,364 | -63.93% | $75,996.00 |
| Russell Investments Group, Ltd. | 31 Mar, 2026 | 23,307 | 7,341 | 45.98% | $74,116.00 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 31 Mar, 2026 | 21,438 | -21,787 | -50.40% | $68,173.00 |